CHMP recommends five new medicines including J&J's Incivo and Zytiga
This article was originally published in Scrip
Executive Summary
European Medicines Agency experts were busy at the July meeting of the Committee Medicinal Products for Human Use (CHMP). In addition to recommending European approval of five new medicines, the committee also supported authorisation of 11 formulations of four generic medicines, while adopting positive opinion for extending the therapeutic indications of three top selling drugs.